Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
advice, afflicted, ARTG, aspect, attend, Australian, bandwidth, behavior, Biden, Blaine, burden, carryforward, Chancery, choice, Circuit, cleaning, Cloud, Codification, collateral, color, complaint, conditionally, Council, CTN, CTX, decade, decoy, deposit, DGCL, differential, disability, discrimination, distancing, doctrine, duty, emphasize, encouraged, enumerated, ESPP, ethnicity, exhibit, extinguishment, facially, fiduciary, forum, fullest, harassment, home, honest, hosting, house, HREC, immunomodulatory, inapplicable, Instruction, intranasal, journal, lab, leave, lethal, malware, NOL, Notification, notified, organisation, orientation, payroll, plant, point, pre, predecessor, prefunded, quarantine, race, reclassification, reclassified, religion, rental, rule, salary, sanitizer, Science, sex, shift, software, subunit, suit, Suite, sum, Syrian, TGA, timeline, unlimited, unpatented, unused, wearing, wellbeing, workplace
Removed:
AB, accrual, adjusted, anniversary, antidilutive, assessing, attribute, Biolipox, British, CAD, Columbia, commencing, comparison, component, Composite, compound, computation, consisting, consult, contracted, currency, daily, deduction, denominated, elimination, Euro, expended, expiring, expiry, flat, formed, Frameworkissued, GCP, hedge, hypothetical, Index, inflation, inInternal, insignificant, intensive, irrespective, Japan, largest, marginal, match, maturity, maximizing, month, offshore, overhaul, partly, pivotal, practical, principally, provincial, recurring, region, reinvestment, repatriated, retrospective, settlement, StemCell, stipulated, sustained, Sweden, taxation, telephone, translated, translation, twelve, UBC, unclaimed, urge, vest
Filing tables
Filing exhibits
Related press release
Associated NGNE transcripts
NGNE similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement Nos. 333-194490, 333-203179, 333-210172, 333-216572, 333-223589, 333-234734, 333-237124 and 333-238021 on Form S-8 and No. 333-251294 on Form S-3 of our report dated March 25, 2021, relating to the financial statements of Neoleukin Therapeutics, Inc. appearing in this Annual Report on Form 10-K of Neoleukin Therapeutics, Inc. for the year ended December 31, 2020.
/s/ Deloitte & Touche LLP
Seattle, Washington
March 25, 2021